Arteriovenous Fistula Treatment Market
Arteriovenous Fistula Treatment is Increasingly Becoming Popular with its Rising Efficiency. Discover the Key Trends
Arteriovenous Fistula Treatment Market by Type, Treatment Type & Region - Forecast 2022 - 2032
Arteriovenous Fistula Treatment Market Outlook (2022-2032)
[340 Pages Report] The global arteriovenous fistula treatment market is projected to amass revenue of about US$ 1,381.1 Mn by 2032, up from US$ 731.6 Mn in 2022, advancing at a CAGR of 5.9% during the forecast period.
In the near future, the market for arteriovenous fistulas is also likely to be boosted by the huge number of medicines in the clinical pipeline and supportive government efforts. However, risks associated with arteriovenous fistula needles are likely to create a dent in the growth of the market share.
The clearance given by FDI of Vascugel, which is an investigational novel medication for the treatment of failed hemodialysis access grafts, for a pivotal phase III trial by Pervasis Therapeutics, Inc. is one such instance. Therefore, these government initiatives and approvals are expected to open up a wide array of arteriovenous fistula treatment market opportunities and a sound foundation for the expansion of this market.
|
Report Attribute |
Details |
|
Arteriovenous Fistula Treatment Market Value (2022) |
US$ 731.6 Mn |
|
Arteriovenous Fistula Treatment Market Anticipated Forecast Value (2032) |
US$ 1,381.1 Mn |
|
Arteriovenous Fistula Treatment Market Projected Growth Rate (2022-2032) |
5.9% |
Due to ongoing efforts by leading companies to provide cutting-edge therapies for the treatment of arteriovenous fistula, the market for arteriovenous fistula treatment market size is expanding rapidly on a global scale. For instance, in April 2013, Shire released the results of a phase II research to determine the effectiveness and safety of SRM003 (Vascugel) in patients with end-stage renal disease and an arteriovenous fistula.
As per the arteriovenous fistula treatment market report by FMI, the arteriovenous fistula treatment methods are in research to come up in the market and the same are also likely to sway the market.
For doctors to pinpoint the precise size and location of damaged blood arteries, imaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI) are helpful, catering to the arteriovenous fistula treatment market growth. To effectively treat arteriovenous fistulas, additional surgical procedures are carried out, and in order to reduce blood clotting to the affected locations as fistula in the brain and eye are tough to cure, injectable treatment is employed in this instance.
Let us know your requirement to get
100% FREE customization
What Factors are Spearheading the Arteriovenous Fistula Treatment Market?
The adoption of arteriovenous fistula treatment is growing over the forecast period as the players are coming up with new treatment methods, is photodynamic therapy, antiangiogenic therapy and another method of sclerotherapy.
The effective treatment method for complete cure in an easy way is still under development process, which initiates the players to come up with new innovations for the treatment, shaping the market trends.
On the flip side, the lack of awareness in regard to the arteriovenous fistula treatment is a hindrance to the demand for arteriovenous fistula treatment worldwide.
The market of arteriovenous fistula treatment bears a huge potential as the treatment methods are limited and the number of population effect is high, directly influencing the market growth.
Which Region is Expected to be at the Forefront of the Arteriovenous Fistula Treatment Market?
Due to the successful measures taken by the US government to create novel therapies for the arteriovenous fistula problem, North America controls the majority of the global arteriovenous fistula treatment market share accounting for 37.0% in 2022.
In addition to this, North America has a huge potential as major pharmaceutical players are placed in that region, in turn positively impacting the arteriovenous fistula treatment market of the region over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Growth Prospects for the Europe Arteriovenous Fistula Treatment Market?
The second-largest market for arteriovenous fistulas is anticipated to be in Europe, with a share of 27% in 2022. Arteriovenous fistula incidence is rising, and there is a strong need for medicines to treat them in Europe, which is mostly responsible for the market's expansion in the region during the forecast period.
Furthermore, Europe's arteriovenous fistula treatment market growth has been soaring, attributed to rising awareness of the treatment in the region.
How is the Start-up Ecosystem in the Arteriovenous Fistula Treatment Market?
Numerous start-ups have been emerging in various industries including the arteriovenous fistula treatment market, who are bringing about emerging trends in the arteriovenous fistula treatment market.
Example:
To raise the marketing of its FDA-cleared implant that enables patients with end-stage renal disease (ESRD) to more easily access their vascular system for hemodialysis, Vital Access, a start-up, obtained a US$10 Mn credit line from Deerfield Management.
The Salt Lake City, Utah-based company's device was approved by the FDA in 2013.
In 96% of patients with fistulas that had been confirmed to be uncannulatable in the SAVE research, a prospective, pivotal clinical trial in the United States, it was demonstrated that VWING provided dependable fistula access.
In comparison to published rates, its usage in the study was linked to a significantly decreased incidence of access site and systemic infection over the long term.
A unified Market Research Subscription Platform, built for today's disparate research needs.
What is the Competition Landscape in the Arteriovenous Fistula Treatment Market?
Players in the market are engaging in various organic and inorganic strategies including mergers & acquisitions, partnerships, product launches, and collaborations, thereby augmenting their arteriovenous fistula treatment market share.
Recent development:
The WavelinQTM 4F EndoAVF System, BD's next-generation technology, provides additional places to establish an AV fistula while leaving open the possibility of creating AV fistulas by regular surgical procedures in the future.
The surgical scar that is frequently left behind after creating an AV fistula during open surgery is removed with the endovascular technique, which is carried out through two tiny punctures or incisions.
Patients who are concerned about AV fistula formation with standard surgery may opt for an endoAVF.
Key Players
- Becton Dickinson & Company – They are an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
- Medtronic – They are the global leader in medical technology, services, and solutions. They collaborate with others to take on healthcare's greatest challenges.
- B. Braun Melsungen Ag – They develop effective solutions and guiding standards for the healthcare system in a constructive dialogue with our customers and partners.
- Cook Medical - They are an American privately held company based in Bloomington, Indiana, and primarily involved in manufacturing of medical devices. They were ranked #324 in Forbes' 2008 America's Largest Private Companies.
- Teleflex Incorporated - They are an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of US$ 2.4 Bn, operations in 40 countries, and more than 12,000 employees.
Other Market Participants:
- Fresenius Medical Care AG & Co. KGaA
- NxStage Medical, Inc.
- Poly Medicure Limited.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 5.9% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Arteriovenous Fistula Treatment Market Survey
By Type:
- Arteriovenous Fistulas
- Dural Arteriovenous Fistulas
- Peripheral Arteriovenous Fistulas
- Pial or Cerebral Arteriovenous Fistulas
- Others
By Treatment Type:
- Drugs
- Transcatheter Embolization
- Ultrasound-guided Compression
- Surgery
By Region:
- North America
- Latin America
- Asia Pacific
- The Middle East and Africa
- Europe
Frequently Asked Questions
The global arteriovenous fistula treatment market is likely to advance at 5.9% CAGR (2022-2032).
North America is projected to lead the arteriovenous fistula treatment market with a revenue of 37.0% in 2022.
Arteriovenous fistula treatment market is anticipated to account for US$ 1,381.1 Mn by 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032
5.3.1. Arteriovenous Fistulas
5.3.2. Dural Arteriovenous Fistulas
5.3.3. Peripheral Arteriovenous Fistulas
5.3.4. Pial or Cerebral Arteriovenous Fistulas
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Type, 2022-2032
6. Global Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Treatment Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Treatment Type, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment Type, 2022-2032
6.3.1. Drugs
6.3.2. Transcatheter Embolization
6.3.3. Ultrasound-guided Compression
6.3.4. Surgery
6.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2017-2021
6.5. Absolute $ Opportunity Analysis By Treatment Type, 2022-2032
7. Global Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. US
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By Treatment Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By Treatment Type
8.4. Key Takeaways
9. Latin America Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Type
9.2.3. By Treatment Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Treatment Type
9.4. Key Takeaways
10. Europe Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Type
10.2.3. By Treatment Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Treatment Type
10.4. Key Takeaways
11. Asia Pacific Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Rest of Asia Pacific
11.2.2. By Type
11.2.3. By Treatment Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Treatment Type
11.4. Key Takeaways
12. MEA Arteriovenous Fistula Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Type
12.2.3. By Treatment Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Treatment Type
12.4. Key Takeaways
13. Key Countries Arteriovenous Fistula Treatment Market Analysis
13.1. US
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Type
13.1.2.2. By Treatment Type
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Type
13.2.2.2. By Treatment Type
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Type
13.3.2.2. By Treatment Type
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Type
13.4.2.2. By Treatment Type
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Type
13.5.2.2. By Treatment Type
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Type
13.6.2.2. By Treatment Type
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Type
13.7.2.2. By Treatment Type
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Type
13.8.2.2. By Treatment Type
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Type
13.9.2.2. By Treatment Type
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Type
13.10.2.2. By Treatment Type
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Type
13.11.2.2. By Treatment Type
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Type
13.12.2.2. By Treatment Type
13.13. GCC Countries
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Type
13.13.2.2. By Treatment Type
13.14. South Africa
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Type
13.14.2.2. By Treatment Type
13.15. Israel
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Type
13.15.2.2. By Treatment Type
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Type
14.3.3. By Treatment Type
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Becton Dickinson & Company
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Medtronic
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Braun Melsungen
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Cook Medical
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Teleflex Incorporated
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Fresenius Medical Care
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. NxStage Medical
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Poly Medicure Limited
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Shire plc
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Mayo Clinic
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Proteon Therapeutics
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 3: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032
Table 4: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 6: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032
Table 7: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 9: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032
Table 10: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 12: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032
Table 13: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 15: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032
Table 16: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 18: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) by Type, 2022-2032
Figure 2: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032
Figure 3: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 8: Global Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 9: Global Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 10: Global Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032
Figure 11: Global Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032
Figure 12: Global Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032
Figure 13: Global Arteriovenous Fistula Treatment Market Attractiveness by Type, 2022-2032
Figure 14: Global Arteriovenous Fistula Treatment Market Attractiveness by Treatment Type, 2022-2032
Figure 15: Global Arteriovenous Fistula Treatment Market Attractiveness by Region, 2022-2032
Figure 16: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) by Type, 2022-2032
Figure 17: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032
Figure 18: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 23: North America Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 24: North America Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 25: North America Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032
Figure 26: North America Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032
Figure 27: North America Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032
Figure 28: North America Arteriovenous Fistula Treatment Market Attractiveness by Type, 2022-2032
Figure 29: North America Arteriovenous Fistula Treatment Market Attractiveness by Treatment Type, 2022-2032
Figure 30: North America Arteriovenous Fistula Treatment Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) by Type, 2022-2032
Figure 32: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032
Figure 33: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 38: Latin America Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 39: Latin America Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 40: Latin America Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032
Figure 41: Latin America Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032
Figure 42: Latin America Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032
Figure 43: Latin America Arteriovenous Fistula Treatment Market Attractiveness by Type, 2022-2032
Figure 44: Latin America Arteriovenous Fistula Treatment Market Attractiveness by Treatment Type, 2022-2032
Figure 45: Latin America Arteriovenous Fistula Treatment Market Attractiveness by Country, 2022-2032
Figure 46: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) by Type, 2022-2032
Figure 47: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032
Figure 48: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 53: Europe Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 54: Europe Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 55: Europe Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032
Figure 56: Europe Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032
Figure 57: Europe Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032
Figure 58: Europe Arteriovenous Fistula Treatment Market Attractiveness by Type, 2022-2032
Figure 59: Europe Arteriovenous Fistula Treatment Market Attractiveness by Treatment Type, 2022-2032
Figure 60: Europe Arteriovenous Fistula Treatment Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) by Type, 2022-2032
Figure 62: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032
Figure 63: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: Asia Pacific Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 68: Asia Pacific Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 69: Asia Pacific Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 70: Asia Pacific Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032
Figure 71: Asia Pacific Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032
Figure 72: Asia Pacific Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032
Figure 73: Asia Pacific Arteriovenous Fistula Treatment Market Attractiveness by Type, 2022-2032
Figure 74: Asia Pacific Arteriovenous Fistula Treatment Market Attractiveness by Treatment Type, 2022-2032
Figure 75: Asia Pacific Arteriovenous Fistula Treatment Market Attractiveness by Country, 2022-2032
Figure 76: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) by Type, 2022-2032
Figure 77: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032
Figure 78: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: MEA Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 83: MEA Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 84: MEA Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 85: MEA Arteriovenous Fistula Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032
Figure 86: MEA Arteriovenous Fistula Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032
Figure 87: MEA Arteriovenous Fistula Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032
Figure 88: MEA Arteriovenous Fistula Treatment Market Attractiveness by Type, 2022-2032
Figure 89: MEA Arteriovenous Fistula Treatment Market Attractiveness by Treatment Type, 2022-2032
Figure 90: MEA Arteriovenous Fistula Treatment Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
